199 related articles for article (PubMed ID: 34978397)
1. Neoteric Approach of Fluoxetine Laden Orodispersible Film for Non-compliant Pediatric Patients of Selective Mutism and Obsessive-compulsive Disorder.
Dad HA; Shabbir AS; Ali S; Mahmood T
Turk J Pharm Sci; 2021 Dec; 18(6):683-694. PubMed ID: 34978397
[TBL] [Abstract][Full Text] [Related]
2. Development, In Vitro and In Vivo Evaluation of Racecadotril Orodispersible Films for Pediatric Use.
Wang B; Yang L; Wang B; Luo C; Wang Y; Wang H; Chen F; Xiang X
AAPS PharmSciTech; 2021 Jan; 22(1):15. PubMed ID: 33389269
[TBL] [Abstract][Full Text] [Related]
3. Development of Polyvinyl Alcohol/Polyethylene Glycol Copolymer-based Orodispersible Films Loaded with Entecavir: Formulation and In vitro Characterization.
Wei T; Zhou BY; Wu XH; Liu XA; Huo MW; Huang XX; Shi LZ; Shi LL; Cao QR
Curr Drug Deliv; 2023 Oct; ():. PubMed ID: 37929732
[TBL] [Abstract][Full Text] [Related]
4. Hydroxypropyl Methylcellulose E15: A Hydrophilic Polymer for Fabrication of Orodispersible Film Using Syringe Extrusion 3D Printer.
Panraksa P; Udomsom S; Rachtanapun P; Chittasupho C; Ruksiriwanich W; Jantrawut P
Polymers (Basel); 2020 Nov; 12(11):. PubMed ID: 33198094
[TBL] [Abstract][Full Text] [Related]
5. Preparation and Evaluation of Caffeine Orodispersible Films: The Influence of Hydrotropic Substances and Film-Forming Agent Concentration on Film Properties.
Vlad RA; Pintea A; Coaicea M; Antonoaea P; Rédai EM; Todoran N; Ciurba A
Polymers (Basel); 2023 Apr; 15(9):. PubMed ID: 37177181
[TBL] [Abstract][Full Text] [Related]
6. Prolonged release from orodispersible films by incorporation of diclofenac-loaded micropellets.
Speer I; Lenhart V; Preis M; Breitkreutz J
Int J Pharm; 2019 Jan; 554():149-160. PubMed ID: 30414477
[TBL] [Abstract][Full Text] [Related]
7. Development and Characterization of Pullulan-Based Orodispersible Films of Iron.
Gupta MS; Kumar TP; Reddy D; Pathak K; Gowda DV; Babu AVN; Aodah AH; Khafagy ES; Alotaibi HF; Abu Lila AS; Moin A; Hussin T
Pharmaceutics; 2023 Mar; 15(3):. PubMed ID: 36986887
[TBL] [Abstract][Full Text] [Related]
8. Hydroxypropyl Methylcellulose Orodispersible Film Containing Desloratadine for Geriatric Use: Formulation and Evaluation.
Al-Oran AYF; Yenilmez E
Antiinflamm Antiallergy Agents Med Chem; 2023; 22(2):79-91. PubMed ID: 37904551
[TBL] [Abstract][Full Text] [Related]
9. Preparation, characterization and in vitro evaluation of a polyvinyl alcohol/sodium alginate based orodispersible film containing sildenafil citrate.
Shi LL; Xu WJ; Cao QR; Yang M; Cui JH
Pharmazie; 2014 May; 69(5):327-34. PubMed ID: 24855822
[TBL] [Abstract][Full Text] [Related]
10. Understanding the Impact of Multi-factorial Composition on Efficient Loading of the Stable Ketoprofen Nanoparticles on Orodispersible Films Using Box-Behnken Design.
Shah HG; Rathod V; Basim P; Gajera B; Dave RH
J Pharm Sci; 2022 May; 111(5):1451-1462. PubMed ID: 34678275
[TBL] [Abstract][Full Text] [Related]
11. Anti-solvent Precipitation Method Coupled Electrospinning Process to Produce Poorly Water-Soluble Drug-Loaded Orodispersible Films.
Song Q; Guo X; Sun Y; Yang M
AAPS PharmSciTech; 2019 Aug; 20(7):273. PubMed ID: 31385126
[TBL] [Abstract][Full Text] [Related]
12. Fabrication and Characterization of Orodispersible Composite Film from Hydroxypropylmethyl Cellulose-Crosslinked Carboxymethyl Rice Starch.
Kittipongpatana OS; Trisopon K; Wattanaarsakit P; Kittipongpatana N
Membranes (Basel); 2022 Jun; 12(6):. PubMed ID: 35736301
[TBL] [Abstract][Full Text] [Related]
13. Formulation design, characterization and in vitro drug release study of orodispersible film comprising BCS class II drugs.
Sheikh FA; Aamir MN; Shah MA; Ali L; Anwer K; Javaid Z
Pak J Pharm Sci; 2020 Jan; 33(1(Supplementary)):343-353. PubMed ID: 32122867
[TBL] [Abstract][Full Text] [Related]
14. Orodispersible films in individualized pharmacotherapy: The development of a formulation for pharmacy preparations.
Visser JC; Woerdenbag HJ; Crediet S; Gerrits E; Lesschen MA; Hinrichs WLJ; Breitkreutz J; Frijlink HW
Int J Pharm; 2015 Jan; 478(1):155-163. PubMed ID: 25448577
[TBL] [Abstract][Full Text] [Related]
15. Characterization of Hydrophilic Polymers as a Syringe Extrusion 3D Printing Material for Orodispersible Film.
Panraksa P; Qi S; Udomsom S; Tipduangta P; Rachtanapun P; Jantanasakulwong K; Jantrawut P
Polymers (Basel); 2021 Oct; 13(20):. PubMed ID: 34685213
[TBL] [Abstract][Full Text] [Related]
16. A novel unit-dose approach for the pharmaceutical compounding of an orodispersible film.
Foo WC; Khong YM; Gokhale R; Chan SY
Int J Pharm; 2018 Mar; 539(1-2):165-174. PubMed ID: 29414124
[TBL] [Abstract][Full Text] [Related]
17. [Preparation and quality evaluation of orodispersible film containing ginkgolide B novel nanosuspension lyophilized powder].
Jing W; Jun-Jun Z; Bao-de S; Ting Z; Bo D; Ya-Ning Z; Hai-Long Y
Zhongguo Zhong Yao Za Zhi; 2020 Nov; 45(22):5504-5510. PubMed ID: 33350212
[TBL] [Abstract][Full Text] [Related]
18. Effect of polymer, plasticizer and filler on orally disintegrating film.
Liew KB; Tan YT; Peh KK
Drug Dev Ind Pharm; 2014 Jan; 40(1):110-9. PubMed ID: 23311593
[TBL] [Abstract][Full Text] [Related]
19. Rizatriptan-Loaded Oral Fast Dissolving Films: Design and Characterizations.
Shah KA; Li G; Song L; Gao B; Huang L; Luan D; Iqbal H; Cao Q; Menaa F; Lee BJ; Alnasser SM; Alshahrani SM; Cui J
Pharmaceutics; 2022 Dec; 14(12):. PubMed ID: 36559181
[TBL] [Abstract][Full Text] [Related]
20. Orodispersible Film (ODF) Platform Based on Maltodextrin for Therapeutical Applications.
Cupone IE; Sansone A; Marra F; Giori AM; Jannini EA
Pharmaceutics; 2022 Sep; 14(10):. PubMed ID: 36297447
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
